Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dna X (SONM) Revenue (2018 - 2025)

Dna X's Revenue history spans 8 years, with the latest figure at $16.2 million for Q3 2025.

  • Quarterly results put Revenue at $16.2 million for Q3 2025, up 7.94% from a year ago — trailing twelve months through Dec 2025 was $44.1 million (down 33.1% YoY), and the annual figure for FY2024 was $58.3 million, down 37.74%.
  • Revenue for Q3 2025 was $16.2 million at Dna X, up from $11.2 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $27.6 million in Q3 2023 to a low of $11.2 million in Q2 2025.
  • The 5-year median for Revenue is $15.9 million (2021), against an average of $17.3 million.
  • The sharpest move saw Revenue surged 124.47% in 2023, then plummeted 57.09% in 2024.
  • Year by year, Revenue stood at $15.9 million in 2021, then soared by 51.39% to $24.1 million in 2022, then plummeted by 44.32% to $13.4 million in 2023, then soared by 68.59% to $22.6 million in 2024, then decreased by 28.39% to $16.2 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $16.2 million, $11.2 million, and $16.7 million for Q3 2025, Q2 2025, and Q1 2025 respectively.